329 related articles for article (PubMed ID: 24232731)
21. Impact of the gut microbiota, prebiotics, and probiotics on human health and disease.
Lin CS; Chang CJ; Lu CC; Martel J; Ojcius DM; Ko YF; Young JD; Lai HC
Biomed J; 2014; 37(5):259-68. PubMed ID: 25179725
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiota, low-grade inflammation, and metabolic syndrome.
Chassaing B; Gewirtz AT
Toxicol Pathol; 2014 Jan; 42(1):49-53. PubMed ID: 24285672
[TBL] [Abstract][Full Text] [Related]
23. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.
Caesar R; Fåk F; Bäckhed F
J Intern Med; 2010 Oct; 268(4):320-8. PubMed ID: 21050286
[TBL] [Abstract][Full Text] [Related]
24. Effects of almond and pistachio consumption on gut microbiota composition in a randomised cross-over human feeding study.
Ukhanova M; Wang X; Baer DJ; Novotny JA; Fredborg M; Mai V
Br J Nutr; 2014 Jun; 111(12):2146-52. PubMed ID: 24642201
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota and obesity: lessons from the microbiome.
Cani PD
Brief Funct Genomics; 2013 Jul; 12(4):381-7. PubMed ID: 23616309
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota and non-alcoholic fatty liver disease: new insights.
Aron-Wisnewsky J; Gaborit B; Dutour A; Clement K
Clin Microbiol Infect; 2013 Apr; 19(4):338-48. PubMed ID: 23452163
[TBL] [Abstract][Full Text] [Related]
27. The gut microbial metabolome: modulation of cancer risk in obese individuals.
Russell WR; Duncan SH; Flint HJ
Proc Nutr Soc; 2013 Feb; 72(1):178-88. PubMed ID: 23174203
[TBL] [Abstract][Full Text] [Related]
28. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
[TBL] [Abstract][Full Text] [Related]
29. Obesity and the human microbiome.
Ley RE
Curr Opin Gastroenterol; 2010 Jan; 26(1):5-11. PubMed ID: 19901833
[TBL] [Abstract][Full Text] [Related]
30. Understanding the role of gut microbiome in metabolic disease risk.
Sanz Y; Olivares M; Moya-Pérez Á; Agostoni C
Pediatr Res; 2015 Jan; 77(1-2):236-44. PubMed ID: 25314581
[TBL] [Abstract][Full Text] [Related]
31. The role of gut microbiota in human obesity: recent findings and future perspectives.
Tagliabue A; Elli M
Nutr Metab Cardiovasc Dis; 2013 Mar; 23(3):160-8. PubMed ID: 23149072
[TBL] [Abstract][Full Text] [Related]
32. Obesity, metabolic syndrome, and microbiota: multiple interactions.
Tilg H
J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S16-8. PubMed ID: 20535027
[TBL] [Abstract][Full Text] [Related]
33. Childhood obesity: a role for gut microbiota?
Sanchez M; Panahi S; Tremblay A
Int J Environ Res Public Health; 2014 Dec; 12(1):162-75. PubMed ID: 25546278
[TBL] [Abstract][Full Text] [Related]
34. Obesity - extending the hygiene hypothesis.
Isolauri E; Kalliomäki M; Rautava S; Salminen S; Laitinen K
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():75-85; discussion 85-9, 251-7. PubMed ID: 19710516
[TBL] [Abstract][Full Text] [Related]
35. Sources, isolation, characterisation and evaluation of probiotics.
Fontana L; Bermudez-Brito M; Plaza-Diaz J; Muñoz-Quezada S; Gil A
Br J Nutr; 2013 Jan; 109 Suppl 2():S35-50. PubMed ID: 23360880
[TBL] [Abstract][Full Text] [Related]
36. Interaction between obesity and the gut microbiota: relevance in nutrition.
Delzenne NM; Cani PD
Annu Rev Nutr; 2011 Aug; 31():15-31. PubMed ID: 21568707
[TBL] [Abstract][Full Text] [Related]
37. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding.
Cani PD; Delzenne NM; Amar J; Burcelin R
Pathol Biol (Paris); 2008 Jul; 56(5):305-9. PubMed ID: 18178333
[TBL] [Abstract][Full Text] [Related]
38. Microecology, obesity, and probiotics.
Tennyson CA; Friedman G
Curr Opin Endocrinol Diabetes Obes; 2008 Oct; 15(5):422-7. PubMed ID: 18769213
[TBL] [Abstract][Full Text] [Related]
39. Role of the gut microbiota in human nutrition and metabolism.
Ramakrishna BS
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():9-17. PubMed ID: 24251697
[TBL] [Abstract][Full Text] [Related]
40. Gut microbiome and metabolic diseases.
Fukuda S; Ohno H
Semin Immunopathol; 2014 Jan; 36(1):103-14. PubMed ID: 24196453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
